Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siranjeevi Nagaraj

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Bioengineering and Biotechnology|November 21, 2022
RNA sensor response in HeLa cells for transfected mRNAs prepared <i>in vitro</i> by SP6 and HiT7 RNA polymerases: A comparative studySiranjeevi Nagaraj, Anna Stankiewicz-Drogon, Edward Darzynkiewicz, et al.
Scientific Reports|February 20, 2024
miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levelsSiranjeevi Nagaraj, Anna Stankiewicz-Drogon, Edward Darzynkiewicz, et al.
Ageing Research Reviews|November 5, 2018
microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancerSiranjeevi Nagaraj, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, et al.
ACS Chemical Neuroscience|February 21, 2019
TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral SclerosisValle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, et al.
Molecular Neurobiology|July 22, 2018
Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS PatientsDiana Posa, Loreto Martínez-González, Fernando Bartolomé, et al.
International Journal of Molecular Sciences|April 30, 2021
Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 RepressionSiranjeevi Nagaraj, Andrew Want, Katarzyna Laskowska-Kaszub, et al.
Molecular Therapy. Nucleic Acids|August 17, 2023
Mesenchymal stem cell engineering by ARCA analog-capped mRNAAnna Andrzejewska, Renata Grzela, Anna Stankiewicz-Drogon, et al.
Oncotarget|February 10, 2017
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjectsSiranjeevi Nagaraj, Katarzyna Laskowska-Kaszub, Konrad J Dębski, et al.
Neurobiology of Disease|March 17, 2025
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkersEva P Cuevas, Enrique Madruga, Ignacio Valenzuela-Martínez, et al.
Frontiers in Molecular Neuroscience|July 10, 2024
Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's diseaseSiranjeevi Nagaraj, Carolina Quintanilla-Sánchez, Kunie Ando, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Bioengineering and Biotechnology|November 21, 2022
RNA sensor response in HeLa cells for transfected mRNAs prepared <i>in vitro</i> by SP6 and HiT7 RNA polymerases: A comparative studySiranjeevi Nagaraj, Anna Stankiewicz-Drogon, Edward Darzynkiewicz, et al.
Scientific Reports|February 20, 2024
miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levelsSiranjeevi Nagaraj, Anna Stankiewicz-Drogon, Edward Darzynkiewicz, et al.
Ageing Research Reviews|November 5, 2018
microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancerSiranjeevi Nagaraj, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, et al.
ACS Chemical Neuroscience|February 21, 2019
TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral SclerosisValle Palomo, Carlota Tosat-Bitrian, Vanesa Nozal, et al.
Molecular Neurobiology|July 22, 2018
Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS PatientsDiana Posa, Loreto Martínez-González, Fernando Bartolomé, et al.
International Journal of Molecular Sciences|April 30, 2021
Candidate Alzheimer's Disease Biomarker miR-483-5p Lowers TAU Phosphorylation by Direct ERK1/2 RepressionSiranjeevi Nagaraj, Andrew Want, Katarzyna Laskowska-Kaszub, et al.
Molecular Therapy. Nucleic Acids|August 17, 2023
Mesenchymal stem cell engineering by ARCA analog-capped mRNAAnna Andrzejewska, Renata Grzela, Anna Stankiewicz-Drogon, et al.
Oncotarget|February 10, 2017
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjectsSiranjeevi Nagaraj, Katarzyna Laskowska-Kaszub, Konrad J Dębski, et al.
Neurobiology of Disease|March 17, 2025
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkersEva P Cuevas, Enrique Madruga, Ignacio Valenzuela-Martínez, et al.
Frontiers in Molecular Neuroscience|July 10, 2024
Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's diseaseSiranjeevi Nagaraj, Carolina Quintanilla-Sánchez, Kunie Ando, et al.
Pageof 2